|
EP2364368B1
(en)
|
2008-11-07 |
2014-01-15 |
Sequenta, Inc. |
Methods of monitoring conditions by sequence analysis
|
|
US9528160B2
(en)
|
2008-11-07 |
2016-12-27 |
Adaptive Biotechnolgies Corp. |
Rare clonotypes and uses thereof
|
|
US8628927B2
(en)
|
2008-11-07 |
2014-01-14 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
|
US8748103B2
(en)
|
2008-11-07 |
2014-06-10 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
|
US9506119B2
(en)
|
2008-11-07 |
2016-11-29 |
Adaptive Biotechnologies Corp. |
Method of sequence determination using sequence tags
|
|
US9365901B2
(en)
|
2008-11-07 |
2016-06-14 |
Adaptive Biotechnologies Corp. |
Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
|
|
ES2568509T3
(es)
|
2009-01-15 |
2016-04-29 |
Adaptive Biotechnologies Corporation |
Perfilado de la inmunidad adaptativa y métodos para la generación de anticuerpos monoclonales
|
|
CA2765949C
(en)
|
2009-06-25 |
2016-03-29 |
Fred Hutchinson Cancer Research Center |
Method of measuring adaptive immunity
|
|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2857499A1
(en)
|
2010-10-01 |
2015-04-08 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
LT2714071T
(lt)
|
2011-05-24 |
2019-10-10 |
Biontech Rna Pharmaceuticals Gmbh |
Individualizuotos vakcinos nuo vėžio
|
|
US10385475B2
(en)
|
2011-09-12 |
2019-08-20 |
Adaptive Biotechnologies Corp. |
Random array sequencing of low-complexity libraries
|
|
HK1201565A1
(en)
|
2011-10-21 |
2015-09-04 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
|
EP3388535B1
(en)
|
2011-12-09 |
2021-03-24 |
Adaptive Biotechnologies Corporation |
Diagnosis of lymphoid malignancies and minimal residual disease detection
|
|
US9499865B2
(en)
|
2011-12-13 |
2016-11-22 |
Adaptive Biotechnologies Corp. |
Detection and measurement of tissue-infiltrating lymphocytes
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
EP3321378B1
(en)
|
2012-02-27 |
2021-11-10 |
Becton, Dickinson and Company |
Compositions for molecular counting
|
|
US10077478B2
(en)
|
2012-03-05 |
2018-09-18 |
Adaptive Biotechnologies Corp. |
Determining paired immune receptor chains from frequency matched subunits
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
PT2831276T
(pt)
|
2012-05-08 |
2016-07-26 |
Adaptive Biotechnologies Corp |
Composições e método para medição e calibração do viés de amplificação em reações pcr multiplex
|
|
MX364370B
(es)
*
|
2012-07-12 |
2019-04-24 |
Persimmune Inc |
Vacunas contra el cancer personalizadas y terapias de celulas inmunes adoptivas.
|
|
US9512456B2
(en)
|
2012-08-14 |
2016-12-06 |
Modernatx, Inc. |
Enzymes and polymerases for the synthesis of RNA
|
|
US10501801B2
(en)
|
2012-09-28 |
2019-12-10 |
University Of Connecticut |
Identification of tumor-protective epitopes for the treatment of cancers
|
|
EP2904111B1
(en)
|
2012-10-01 |
2017-12-06 |
Adaptive Biotechnologies Corporation |
Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
|
|
WO2015160439A2
(en)
|
2014-04-17 |
2015-10-22 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
AU2013351542B2
(en)
|
2012-11-28 |
2018-08-09 |
BioNTech SE |
Individualized vaccines for cancer
|
|
WO2014093186A1
(en)
*
|
2012-12-12 |
2014-06-19 |
Garvin Alex M |
Non-invasive detection of colorectal neoplasia using circular consensus sequencing
|
|
CN105190656B
(zh)
|
2013-01-17 |
2018-01-16 |
佩索纳里斯公司 |
用于遗传分析的方法和系统
|
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
CA2906218A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Adaptive Biotechnologies Corporation |
Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
|
|
AU2014251207B2
(en)
*
|
2013-04-07 |
2019-06-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
|
WO2014180490A1
(en)
*
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
US9708657B2
(en)
|
2013-07-01 |
2017-07-18 |
Adaptive Biotechnologies Corp. |
Method for generating clonotype profiles using sequence tags
|
|
WO2015013461A2
(en)
*
|
2013-07-26 |
2015-01-29 |
Sequenta, Inc. |
Cancer vaccination with antigen evolution
|
|
CN105705659B
(zh)
|
2013-08-28 |
2019-11-29 |
贝克顿迪金森公司 |
大规模平行单细胞分析
|
|
GB2534067B
(en)
|
2013-08-30 |
2021-07-21 |
Personalis Inc |
Methods and systems for genomic analysis
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
GB2535066A
(en)
|
2013-10-03 |
2016-08-10 |
Personalis Inc |
Methods for analyzing genotypes
|
|
CN105745528A
(zh)
|
2013-10-07 |
2016-07-06 |
赛卢拉研究公司 |
用于以数字方式对阵列上的特征进行计数的方法和系统
|
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
|
ES2693217T3
(es)
*
|
2013-12-02 |
2018-12-10 |
Personal Genome Diagnostics Inc. |
Método para evaluar variantes minoritarias en una muestra
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
JP6740127B2
(ja)
*
|
2013-12-06 |
2020-08-12 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
新生物ワクチン用製剤
|
|
JP7060324B2
(ja)
|
2013-12-20 |
2022-04-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ネオ抗原ワクチンによる併用療法
|
|
CA2941612A1
(en)
|
2014-03-05 |
2015-09-11 |
Adaptive Biotechnologies Corporation |
Methods using randomer-containing synthetic molecules
|
|
US10066265B2
(en)
|
2014-04-01 |
2018-09-04 |
Adaptive Biotechnologies Corp. |
Determining antigen-specific t-cells
|
|
HRP20220070T1
(hr)
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
US10017759B2
(en)
*
|
2014-06-26 |
2018-07-10 |
Illumina, Inc. |
Library preparation of tagged nucleic acid
|
|
EP3194970B1
(en)
|
2014-09-10 |
2021-07-28 |
F. Hoffmann-La Roche AG |
Immunogenic mutant peptide screening platform
|
|
US11338026B2
(en)
|
2014-09-10 |
2022-05-24 |
The University Of Connecticut |
Identification of immunologically protective neo-epitopes for the treatment of cancers
|
|
CN107075479A
(zh)
|
2014-10-02 |
2017-08-18 |
美国卫生和人力服务部 |
分离对癌症特异性突变具有抗原特异性的t细胞的方法
|
|
CA2966201A1
(en)
|
2014-10-29 |
2016-05-06 |
Adaptive Biotechnologies Corp. |
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
|
|
US10125399B2
(en)
|
2014-10-30 |
2018-11-13 |
Personalis, Inc. |
Methods for using mosaicism in nucleic acids sampled distal to their origin
|
|
US10246701B2
(en)
|
2014-11-14 |
2019-04-02 |
Adaptive Biotechnologies Corp. |
Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
|
|
EP3498866B1
(en)
|
2014-11-25 |
2026-02-25 |
Adaptive Biotechnologies Corp. |
Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
|
|
EP3234130B1
(en)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Methods for profiling the t-cell- receptor repertoire
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
WO2016128060A1
(en)
*
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
|
EP3259371B1
(en)
*
|
2015-02-19 |
2020-09-02 |
Becton, Dickinson and Company |
High-throughput single-cell analysis combining proteomic and genomic information
|
|
WO2016138122A1
(en)
|
2015-02-24 |
2016-09-01 |
Adaptive Biotechnologies Corp. |
Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
|
|
CA2977801C
(en)
|
2015-02-26 |
2024-03-19 |
Sio2 Medical Products, Inc. |
Cycloolefin polymer container with a scratch resistant and anti-static coating
|
|
WO2016138496A1
(en)
|
2015-02-27 |
2016-09-01 |
Cellular Research, Inc. |
Spatially addressable molecular barcoding
|
|
CN107406888A
(zh)
|
2015-03-30 |
2017-11-28 |
赛卢拉研究公司 |
用于组合条形编码的方法和组合物
|
|
EP3277294B1
(en)
|
2015-04-01 |
2024-05-15 |
Adaptive Biotechnologies Corp. |
Method of identifying human compatible t cell receptors specific for an antigenic target
|
|
EP3286326B1
(en)
|
2015-04-23 |
2025-01-22 |
Becton, Dickinson and Company |
Method for whole transcriptome amplification
|
|
MX381241B
(es)
*
|
2015-04-27 |
2025-03-12 |
Cancer Research Tech Ltd |
Composición de células t para usarse en el tratamiento del cáncer.
|
|
WO2016180467A1
(en)
|
2015-05-11 |
2016-11-17 |
Biontech Cell & Gene Therapies Gmbh |
Enhancing the effect of car-engineered t cells by means of nucleic acid vaccination
|
|
EP3294324A1
(en)
*
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
JP6913032B2
(ja)
|
2015-05-20 |
2021-08-04 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
共通ネオ抗原
|
|
US11124823B2
(en)
|
2015-06-01 |
2021-09-21 |
Becton, Dickinson And Company |
Methods for RNA quantification
|
|
TW202241500A
(zh)
*
|
2015-06-09 |
2022-11-01 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
EP3328394A4
(en)
*
|
2015-07-30 |
2019-03-13 |
ModernaTX, Inc. |
CONCATEMEE peptide epitope RNAs
|
|
GB201516047D0
(en)
|
2015-09-10 |
2015-10-28 |
Cancer Rec Tech Ltd |
Method
|
|
WO2017044574A1
(en)
|
2015-09-11 |
2017-03-16 |
Cellular Research, Inc. |
Methods and compositions for nucleic acid library normalization
|
|
EP3359670B2
(en)
|
2015-10-05 |
2024-02-14 |
ModernaTX, Inc. |
Methods for therapeutic administration of messenger ribonucleic acid drugs
|
|
WO2017059902A1
(en)
*
|
2015-10-07 |
2017-04-13 |
Biontech Rna Pharmaceuticals Gmbh |
3' utr sequences for stabilization of rna
|
|
CN108601820A
(zh)
*
|
2015-10-12 |
2018-09-28 |
南托米克斯有限责任公司 |
用于病毒癌症新表位的组合物和方法
|
|
WO2017066290A1
(en)
*
|
2015-10-12 |
2017-04-20 |
Nantomics, Llc |
Viral neoepitopes and uses thereof
|
|
EP3364949A4
(en)
*
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
CANCER VACCINES
|
|
JP7114477B2
(ja)
|
2015-12-16 |
2022-08-08 |
グリットストーン バイオ インコーポレイテッド |
新生抗原の特定、製造、および使用
|
|
CN105349533A
(zh)
*
|
2015-12-21 |
2016-02-24 |
生工生物工程（上海）股份有限公司 |
构建链特异性转录组文库的方法
|
|
JP2019505512A
(ja)
*
|
2016-01-08 |
2019-02-28 |
バッシボディ アクスイェ セルスカプ |
治療用抗癌ネオエピトープワクチン
|
|
WO2017118702A1
(en)
*
|
2016-01-08 |
2017-07-13 |
Vaccibody As |
Neoepitope rna cancer vaccine
|
|
JP2019513021A
(ja)
|
2016-03-24 |
2019-05-23 |
ナントセル，インコーポレイテッド |
ネオエピトープ提示のための配列の配置および配列
|
|
SG11201808196UA
(en)
|
2016-03-31 |
2018-10-30 |
Neon Therapeutics Inc |
Neoantigens and methods of their use
|
|
AU2017254477A1
(en)
|
2016-04-18 |
2018-11-01 |
Jennifer G. ABELIN |
Improved HLA epitope prediction
|
|
EP4487869A3
(en)
*
|
2016-04-22 |
2025-07-30 |
CureVac SE |
Rna encoding a tumor antigen
|
|
EP3452614B1
(en)
|
2016-05-02 |
2023-06-28 |
Becton, Dickinson and Company |
Accurate molecular barcoding
|
|
CN109328070A
(zh)
*
|
2016-05-04 |
2019-02-12 |
免疫疫苗技术有限公司 |
包含两亲化合物、新抗原和疏水载体的疫苗组合物及其使用方法
|
|
WO2017194170A1
(en)
|
2016-05-13 |
2017-11-16 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
|
|
US10301677B2
(en)
|
2016-05-25 |
2019-05-28 |
Cellular Research, Inc. |
Normalization of nucleic acid libraries
|
|
WO2017205691A1
(en)
|
2016-05-26 |
2017-11-30 |
Cellular Research, Inc. |
Molecular label counting adjustment methods
|
|
US11299783B2
(en)
|
2016-05-27 |
2022-04-12 |
Personalis, Inc. |
Methods and systems for genetic analysis
|
|
EP3735984A1
(en)
*
|
2016-05-27 |
2020-11-11 |
Etubics Corporation |
Neoepitope vaccine compositions and methods of use thereof
|
|
US10640763B2
(en)
|
2016-05-31 |
2020-05-05 |
Cellular Research, Inc. |
Molecular indexing of internal sequences
|
|
US10202641B2
(en)
|
2016-05-31 |
2019-02-12 |
Cellular Research, Inc. |
Error correction in amplification of samples
|
|
AU2017295004B2
(en)
*
|
2016-07-13 |
2020-08-13 |
NEC Oncolmmunity AS |
Process for the production of a DNA vaccine for cancer immunotherapy
|
|
CA3031003A1
(en)
*
|
2016-07-20 |
2018-01-25 |
Biontech Rna Pharmaceuticals Gmbh |
Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy
|
|
US10428325B1
(en)
|
2016-09-21 |
2019-10-01 |
Adaptive Biotechnologies Corporation |
Identification of antigen-specific B cell receptors
|
|
IL265478B2
(en)
|
2016-09-26 |
2024-10-01 |
Becton Dickinson Co |
Measurement of protein expression using reagents with barcoded oligonucleotide sequences
|
|
AU2017359048B2
(en)
|
2016-11-08 |
2022-07-21 |
Becton, Dickinson And Company |
Methods for expression profile classification
|
|
CN109906274B
(zh)
|
2016-11-08 |
2023-08-25 |
贝克顿迪金森公司 |
用于细胞标记分类的方法
|
|
US20190321481A1
(en)
|
2016-11-11 |
2019-10-24 |
Nantbio, Inc. |
Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
|
|
CN108090325B
(zh)
*
|
2016-11-23 |
2022-01-25 |
中国科学院昆明动物研究所 |
一种应用β-稳定性分析单细胞测序数据的方法
|
|
WO2018132610A1
(en)
|
2017-01-13 |
2018-07-19 |
Cellular Research, Inc. |
Hydrophilic coating of fluidic channels
|
|
WO2018132753A1
(en)
*
|
2017-01-13 |
2018-07-19 |
Nantbio, Inc. |
Validation of neoepitope-based treatment
|
|
US12331359B2
(en)
*
|
2017-01-18 |
2025-06-17 |
Michael Laessig |
Neoantigens and uses thereof for treating cancer
|
|
EP3574116A1
(en)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
US11319583B2
(en)
|
2017-02-01 |
2022-05-03 |
Becton, Dickinson And Company |
Selective amplification using blocking oligonucleotides
|
|
CA3052255A1
(en)
*
|
2017-02-01 |
2018-08-09 |
Modernatx, Inc. |
Rna cancer vaccines
|
|
MX2019009070A
(es)
|
2017-02-01 |
2019-10-30 |
Modernatx Inc |
Composiciones de arnm terapeuticas inmunomoduladoras que codifican peptidos de mutacion de oncogenes de activacion.
|
|
CN110809716B
(zh)
|
2017-02-12 |
2023-07-07 |
百欧恩泰美国公司 |
基于hla的方法和组合物及其用途
|
|
EP3600357A4
(en)
|
2017-03-31 |
2021-01-06 |
The Board of Trustees of the Leland Stanford Junior University |
METHODS OF TREATING T-LYMPHOCYTE DEPLETION BY INHIBITING OR MODULATING T-LYMPHOCYTE RECEPTOR SIGNALING
|
|
EP3606550A2
(en)
|
2017-04-03 |
2020-02-12 |
Neon Therapeutics, Inc. |
Protein antigens and uses thereof
|
|
MA48047A
(fr)
|
2017-04-05 |
2020-02-12 |
Modernatx Inc |
Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée
|
|
CA3061240C
(en)
|
2017-04-24 |
2024-01-16 |
Nantcell, Inc. |
Targeted neoepitope vectors and methods therefor
|
|
KR102945203B1
(ko)
|
2017-05-08 |
2026-03-31 |
시애틀 프로젝트 코포레이션 |
알파바이러스 신생항원 벡터
|
|
US11464798B2
(en)
|
2017-05-11 |
2022-10-11 |
Theralase Technologies Inc. |
Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same
|
|
WO2018222433A2
(en)
|
2017-05-30 |
2018-12-06 |
Nant Holdings Ip, Llc |
Circulating tumor cell enrichment using neoepitopes
|
|
JP7536450B2
(ja)
|
2017-06-05 |
2024-08-20 |
ベクトン・ディキンソン・アンド・カンパニー |
単一細胞用のサンプルインデックス付加
|
|
WO2018224166A1
(en)
*
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
KR20240113607A
(ko)
|
2017-06-21 |
2024-07-22 |
트랜스진 |
개인 맞춤형 백신
|
|
WO2019005764A1
(en)
|
2017-06-27 |
2019-01-03 |
Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center |
MHC-I GENOTYPE LIMITING THE ONCOGEN MUTATIONAL LANDSCAPE
|
|
US20200230220A1
(en)
*
|
2017-07-12 |
2020-07-23 |
Nouscom Ag |
Neoantigen vaccine composition for treatment of cancer
|
|
AU2018301704A1
(en)
|
2017-07-14 |
2020-03-05 |
Cofactor Genomics, Inc. |
Immuno-oncology applications using next generation sequencing
|
|
EP3688020A4
(en)
|
2017-09-25 |
2021-07-14 |
University of Florida Research Foundation, Incorporated |
IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS
|
|
AU2018342105B2
(en)
|
2017-09-26 |
2023-11-16 |
University Of Florida Research Foundation, Incorporated |
Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
|
|
CN111465989B
(zh)
|
2017-10-10 |
2024-06-25 |
磨石生物公司 |
使用热点进行的新抗原鉴别
|
|
AU2018373154B2
(en)
*
|
2017-11-22 |
2025-08-07 |
Seattle Project Corp. |
Reducing junction epitope presentation for neoantigens
|
|
US20200354730A1
(en)
*
|
2017-11-27 |
2020-11-12 |
Nantcell, Inc. |
Improved Yeast Polytope Vaccine Compositions And Methods
|
|
US11254980B1
(en)
|
2017-11-29 |
2022-02-22 |
Adaptive Biotechnologies Corporation |
Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
|
|
WO2019105485A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
上海桀蒙生物技术有限公司 |
个性化癌症疫苗的制备方法
|
|
TW201930340A
(zh)
|
2017-12-18 |
2019-08-01 |
美商尼恩醫療公司 |
新抗原及其用途
|
|
US11972841B2
(en)
|
2017-12-18 |
2024-04-30 |
Personal Genome Diagnostics Inc. |
Machine learning system and method for somatic mutation discovery
|
|
CN111492068B
(zh)
|
2017-12-19 |
2025-03-21 |
贝克顿迪金森公司 |
与寡核苷酸相关联的颗粒
|
|
KR20240134250A
(ko)
|
2018-01-04 |
2024-09-06 |
아이코닉 테라퓨틱스, 인코포레이티드 |
항-조직 인자 항체, 항체-약물 결합체, 및 관련 방법
|
|
CN112041933B
(zh)
*
|
2018-03-14 |
2025-05-13 |
皇家飞利浦有限公司 |
使用局部独特特征来解释rna测序数据的转录本表达水平的系统和方法
|
|
CA3095030A1
(en)
*
|
2018-03-30 |
2019-10-03 |
Juno Diagnostics, Inc. |
Deep learning-based methods, devices, and systems for prenatal testing
|
|
EP3784688A2
(en)
|
2018-04-26 |
2021-03-03 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|
|
EP3788170B1
(en)
|
2018-05-03 |
2025-01-01 |
Becton, Dickinson and Company |
Molecular barcoding on opposite transcript ends
|
|
CA3097976A1
(en)
|
2018-05-03 |
2019-11-07 |
Becton, Dickinson And Company |
High throughput multiomics sample analysis
|
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
|
US12528848B2
(en)
|
2018-05-25 |
2026-01-20 |
The Wistar Institute Of Anatomy And Biology |
Tumor-specific neoantigens and methods of using the same
|
|
CN108897986B
(zh)
*
|
2018-05-29 |
2020-11-27 |
中南大学 |
一种基于蛋白质信息的基因组序列拼接方法
|
|
US11814750B2
(en)
|
2018-05-31 |
2023-11-14 |
Personalis, Inc. |
Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
|
|
US10801064B2
(en)
|
2018-05-31 |
2020-10-13 |
Personalis, Inc. |
Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
|
|
SG11202012653XA
(en)
|
2018-06-19 |
2021-01-28 |
Biontech Us Inc |
Neoantigens and uses thereof
|
|
US20210268086A1
(en)
*
|
2018-06-27 |
2021-09-02 |
Modernatx, Inc. |
Personalized cancer vaccine epitope selection
|
|
WO2020020444A1
(en)
*
|
2018-07-24 |
2020-01-30 |
Biontech Rna Pharmaceuticals Gmbh |
Individualized vaccines for cancer
|
|
EP3827262A1
(en)
|
2018-07-26 |
2021-06-02 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for breast cancer
|
|
WO2020022897A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database
|
|
BR112021005702A8
(pt)
|
2018-09-27 |
2022-11-08 |
Vaccibody As |
Método para selecionar neoepítopos
|
|
EP3861134B1
(en)
|
2018-10-01 |
2024-09-04 |
Becton, Dickinson and Company |
Determining 5' transcript sequences
|
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
CN109550044B
(zh)
*
|
2018-10-19 |
2022-05-03 |
杭州纽安津生物科技有限公司 |
通用性多肽疫苗及其在制备治疗/预防胰腺癌药物中的应用
|
|
KR20210090650A
(ko)
|
2018-11-07 |
2021-07-20 |
그릿스톤 바이오, 인코포레이티드 |
알파바이러스 신생항원 벡터 및 인터페론 억제제
|
|
MA54192A
(fr)
*
|
2018-11-07 |
2021-09-15 |
Modernatx Inc |
Vaccins à arn contre le cancer
|
|
EP3877520B1
(en)
|
2018-11-08 |
2025-03-19 |
Becton, Dickson And Company |
Whole transcriptome analysis of single cells using random priming
|
|
CN113424264B
(zh)
*
|
2018-11-15 |
2024-04-12 |
Nouscom股份公司 |
用于生成个性化癌症疫苗的癌症突变选择
|
|
EP3894552B1
(en)
|
2018-12-13 |
2026-01-28 |
Becton, Dickinson and Company |
Selective extension in single cell whole transcriptome analysis
|
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
CA3124457A1
(en)
*
|
2018-12-21 |
2020-06-25 |
Biontech Us Inc. |
Method and systems for prediction of hla class ii-specific epitopes and characterization of cd4+ t cells
|
|
GB201821205D0
(en)
*
|
2018-12-24 |
2019-02-06 |
Tcer Ab |
Immunotherapy
|
|
GB201821207D0
(en)
|
2018-12-24 |
2019-02-06 |
Tcer Ab |
Immunotherapy therapy
|
|
AU2020207053B2
(en)
*
|
2019-01-08 |
2025-07-31 |
Caris Mpi, Inc. |
Genomic profiling similarity
|
|
CN115120716A
(zh)
*
|
2019-01-14 |
2022-09-30 |
健泰科生物技术公司 |
用pd-1轴结合拮抗剂和rna疫苗治疗癌症的方法
|
|
WO2020150356A1
(en)
|
2019-01-16 |
2020-07-23 |
Becton, Dickinson And Company |
Polymerase chain reaction normalization through primer titration
|
|
EP3914728B1
(en)
|
2019-01-23 |
2023-04-05 |
Becton, Dickinson and Company |
Oligonucleotides associated with antibodies
|
|
CN113396230A
(zh)
|
2019-02-08 |
2021-09-14 |
豪夫迈·罗氏有限公司 |
癌症的诊断和治疗方法
|
|
CN113454234B
(zh)
|
2019-02-14 |
2025-03-18 |
贝克顿迪金森公司 |
杂合体靶向和全转录物组扩增
|
|
US20220160850A1
(en)
*
|
2019-02-15 |
2022-05-26 |
Rjan Holding Ab |
Autologous cancer tumour associated extrachromosomal circular dna for use as a therapeutic vaccine
|
|
CN113784725A
(zh)
*
|
2019-03-01 |
2021-12-10 |
弗洛制药公司 |
个性化癌症疫苗的设计、制造和用途
|
|
WO2020184551A1
(ja)
|
2019-03-13 |
2020-09-17 |
東洋紡株式会社 |
核酸の生成および増幅
|
|
US11965208B2
(en)
|
2019-04-19 |
2024-04-23 |
Becton, Dickinson And Company |
Methods of associating phenotypical data and single cell sequencing data
|
|
SG11202113187WA
(en)
|
2019-05-30 |
2021-12-30 |
Gritstone Bio Inc |
Modified adenoviruses
|
|
CN112011833B
(zh)
*
|
2019-05-30 |
2024-04-26 |
上海桀蒙生物技术有限公司 |
筛选和分离肿瘤新生抗原的方法
|
|
WO2021028726A2
(en)
*
|
2019-07-03 |
2021-02-18 |
Bostongene Corporation |
Systems and methods for sample preparation, sample sequencing, and sequencing data bias correction and quality control
|
|
WO2021016239A1
(en)
|
2019-07-22 |
2021-01-28 |
Becton, Dickinson And Company |
Single cell chromatin immunoprecipitation sequencing assay
|
|
CN110277135B
(zh)
*
|
2019-08-10 |
2021-06-01 |
杭州新范式生物医药科技有限公司 |
一种基于预期疗效选择个体化肿瘤新抗原的方法和系统
|
|
WO2021055973A2
(en)
*
|
2019-09-20 |
2021-03-25 |
Navi Bio-Therapeutics, Inc. |
Personalized cancer immunotherapy
|
|
AU2020348916B2
(en)
*
|
2019-09-20 |
2025-12-18 |
University Of Florida Research Foundation, Incorporated |
Detection of antibodies against RAN proteins from serum and tissue lysates
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|
|
WO2021072187A2
(en)
|
2019-10-10 |
2021-04-15 |
University Of Florida Research Foundation, Incorporated |
Ran proteins as biomarkers in cag/ctg expansion disorders
|
|
JP7470787B2
(ja)
|
2019-11-05 |
2024-04-18 |
パーソナリス，インコーポレイティド |
単一試料からの腫瘍純度の推定
|
|
EP4055160B1
(en)
|
2019-11-08 |
2024-04-10 |
Becton Dickinson and Company |
Using random priming to obtain full-length v(d)j information for immune repertoire sequencing
|
|
CN112795647B
(zh)
*
|
2019-11-14 |
2022-08-16 |
北京肿瘤医院(北京大学肿瘤医院) |
一种肿瘤标志物及其应用
|
|
CR20220330A
(es)
|
2019-12-13 |
2022-08-04 |
Genentech Inc |
Anticuerpos anti-ly6g6d y métodos de uso.
|
|
CN115279919A
(zh)
|
2020-01-13 |
2022-11-01 |
贝克顿迪金森公司 |
使用含有du的寡核苷酸的细胞捕获
|
|
CN115244184A
(zh)
|
2020-01-13 |
2022-10-25 |
贝克顿迪金森公司 |
用于定量蛋白和rna的方法和组合物
|
|
WO2021155057A1
(en)
|
2020-01-29 |
2021-08-05 |
Becton, Dickinson And Company |
Barcoded wells for spatial mapping of single cells through sequencing
|
|
US12153043B2
(en)
|
2020-02-25 |
2024-11-26 |
Becton, Dickinson And Company |
Bi-specific probes to enable the use of single-cell samples as single color compensation control
|
|
WO2021184017A1
(en)
|
2020-03-13 |
2021-09-16 |
Codiak Biosciences, Inc. |
Extracellular vesicles for treating neurological disorders
|
|
JP2023518414A
(ja)
|
2020-03-20 |
2023-05-01 |
コディアック バイオサイエンシーズ， インコーポレイテッド |
治療のための細胞外小胞
|
|
US11920202B2
(en)
|
2020-04-09 |
2024-03-05 |
University Of Connecticut |
Unbiased identification of tumor rejection mediating neoepitopes
|
|
WO2021205027A1
(en)
|
2020-04-09 |
2021-10-14 |
Vaccibody As |
Individualized therapeutic anticancer vaccine
|
|
WO2021231779A1
(en)
|
2020-05-14 |
2021-11-18 |
Becton, Dickinson And Company |
Primers for immune repertoire profiling
|
|
JP7854946B2
(ja)
|
2020-05-26 |
2026-05-07 |
ディオニス セラピューティクス インコーポレイテッド |
核酸人工ミニプロテオームライブラリー
|
|
CN115803445A
(zh)
|
2020-06-02 |
2023-03-14 |
贝克顿迪金森公司 |
用于5撇基因表达测定的寡核苷酸和珠
|
|
US11932901B2
(en)
|
2020-07-13 |
2024-03-19 |
Becton, Dickinson And Company |
Target enrichment using nucleic acid probes for scRNAseq
|
|
WO2022026909A1
(en)
|
2020-07-31 |
2022-02-03 |
Becton, Dickinson And Company |
Single cell assay for transposase-accessible chromatin
|
|
IL300026A
(en)
|
2020-08-06 |
2023-03-01 |
Gritstone Bio Inc |
Multiepitope vaccine cassettes
|
|
EP4196612A1
(en)
|
2020-08-12 |
2023-06-21 |
Genentech, Inc. |
Diagnostic and therapeutic methods for cancer
|
|
US20230323431A1
(en)
*
|
2020-08-31 |
2023-10-12 |
World Biotech Regenerative Medical Group Limited |
Personalized Immunogenic Compositions and Methods for Producing and Using Same
|
|
WO2022066898A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Methods of producing extracellular vesicles
|
|
WO2022109343A1
(en)
|
2020-11-20 |
2022-05-27 |
Becton, Dickinson And Company |
Profiling of highly expressed and lowly expressed proteins
|
|
US11161892B1
(en)
|
2020-12-07 |
2021-11-02 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
CN116710115A
(zh)
|
2020-11-20 |
2023-09-05 |
思维疗法股份有限公司 |
用于优化的肽疫苗的组合物和方法
|
|
US11058751B1
(en)
|
2020-11-20 |
2021-07-13 |
Think Therapeutics, Inc. |
Compositions for optimized RAS peptide vaccines
|
|
US11421015B2
(en)
|
2020-12-07 |
2022-08-23 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
JP2024501482A
(ja)
|
2020-12-14 |
2024-01-12 |
ビオンテック ユーエス インコーポレイテッド |
がん免疫療法のための組織特異的抗原
|
|
CN116685850A
(zh)
|
2020-12-15 |
2023-09-01 |
贝克顿迪金森公司 |
单细胞分泌组分析
|
|
US11464842B1
(en)
|
2021-04-28 |
2022-10-11 |
Think Therapeutics, Inc. |
Compositions and method for optimized peptide vaccines using residue optimization
|
|
AU2021461416A1
(en)
|
2021-08-24 |
2024-02-22 |
BioNTech SE |
In vitro transcription technologies
|
|
WO2023059654A1
(en)
|
2021-10-05 |
2023-04-13 |
Personalis, Inc. |
Customized assays for personalized cancer monitoring
|
|
US20250011759A1
(en)
|
2021-10-11 |
2025-01-09 |
Toyobo Co., Ltd. |
Improved library preparation method
|
|
WO2023076733A1
(en)
|
2021-11-01 |
2023-05-04 |
Dana-Farber Cancer Institute, Inc. |
Biologically selected nucleic acid artificial mini-proteome libraries
|
|
CN114181287B
(zh)
*
|
2021-12-10 |
2023-09-19 |
商丘美兰生物工程有限公司 |
一种dna病毒疫苗的制备方法
|
|
CN114350800B
(zh)
*
|
2021-12-29 |
2024-03-19 |
中南大学湘雅医院 |
Sphk1在制备pd-l1/pd-1单抗肿瘤免疫治疗药物中的应用
|
|
CN114410778B
(zh)
*
|
2021-12-29 |
2024-03-19 |
中南大学湘雅医院 |
Pf543在制备pd-l1/pd-1单抗肿瘤免疫治疗药物中的应用
|
|
KR102969181B1
(ko)
*
|
2022-03-04 |
2026-05-26 |
(주)큐리진 |
순환종양세포 검출을 위한 아데노바이러스 5/3 형
|
|
EP4253550A1
(en)
|
2022-04-01 |
2023-10-04 |
GenCC GmbH 6 Co. KG |
Method for the manufacture of a viral system, a vector system or any transport system for cancer-specific crispr complexes
|
|
WO2023209068A1
(en)
|
2022-04-28 |
2023-11-02 |
Carbocalyx Gmbh |
Personalized anticancer vaccine comprising glycoengineered tumour cells or tumour cell fragments
|
|
WO2024015892A1
(en)
|
2022-07-13 |
2024-01-18 |
The Broad Institute, Inc. |
Hla-ii immunopeptidome methods and systems for antigen discovery
|
|
WO2024063788A1
(en)
*
|
2022-09-23 |
2024-03-28 |
BioNTech SE |
Compositions for delivery of malaria antigens and related methods
|
|
IL319414A
(en)
*
|
2022-09-23 |
2025-05-01 |
BioNTech SE |
Compositions for delivering antigens at the liver level and related methods
|
|
WO2024083345A1
(en)
|
2022-10-21 |
2024-04-25 |
BioNTech SE |
Methods and uses associated with liquid compositions
|
|
JPWO2024157925A1
(enExample)
|
2023-01-26 |
2024-08-02 |
|
|
|
JP7811691B2
(ja)
*
|
2023-05-08 |
2026-02-05 |
株式会社日立製作所 |
情報処理装置
|
|
US12531162B1
(en)
*
|
2023-05-31 |
2026-01-20 |
Northeastern University |
Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net
|
|
EP4736848A1
(en)
|
2023-06-28 |
2026-05-06 |
Shanghai Regenelead Therapies Co., Ltd. |
Pharmaceutical composition containing cationic lipid and use thereof
|
|
EP4750488A1
(en)
*
|
2023-07-24 |
2026-06-03 |
BioNTech SE |
Compositions for delivery of plasmodium antigens and related methods
|
|
WO2025064850A1
(en)
*
|
2023-09-22 |
2025-03-27 |
BioNTech SE |
Rna constructs with n-terminal degrons to enhance an immune response
|
|
WO2025097055A2
(en)
|
2023-11-02 |
2025-05-08 |
The Broad Institute, Inc. |
Compositions and methods of use of t cells in immunotherapy
|
|
US12562256B2
(en)
*
|
2023-11-07 |
2026-02-24 |
New York University |
Systems, methods and computer-accessible medium for identifying target pairs for CAR-T therapy
|
|
WO2025103414A1
(zh)
|
2023-11-14 |
2025-05-22 |
上海瑞宏迪医药有限公司 |
一种脂质纳米粒的制备方法和应用
|
|
WO2025146078A1
(en)
*
|
2024-01-04 |
2025-07-10 |
Everest Medicines (China) Co., Ltd. |
Cancer vaccines and uses thereof
|
|
WO2025191449A1
(en)
|
2024-03-11 |
2025-09-18 |
Instadeep Ltd |
Systems and methods for machine learning-based genome annotation
|
|
WO2025202937A1
(en)
|
2024-03-26 |
2025-10-02 |
BioNTech SE |
Cancer vaccines
|
|
WO2025207807A1
(en)
*
|
2024-03-27 |
2025-10-02 |
The University Of Florida Research Foundation, Inc. |
Ctc rna-loaded nanoparticles and use thereof for the treatment of cancer
|
|
WO2025257735A1
(en)
|
2024-06-10 |
2025-12-18 |
BioNTech SE |
Systems and methods for machine learning model-based prediction of immune response
|
|
WO2026006629A1
(en)
|
2024-06-27 |
2026-01-02 |
Personalis, Inc. |
System and method for management of compressed sequencing files
|
|
CN119049567B
(zh)
*
|
2024-08-08 |
2025-07-22 |
笙源生命科技(安吉)有限公司 |
一种基于单细胞测序区分嵌合体动物模型中异种杂交样本遗传物质和细胞物种来源的方法
|
|
EP4711456A1
(en)
|
2024-09-11 |
2026-03-18 |
GenCC GmbH & Co. KG |
Method for the manufacture of individualized crispr/cas complexes and individualized crispr/cas complexes
|
|
WO2026096894A1
(en)
|
2024-11-01 |
2026-05-07 |
BioNTech SE |
Methods and systems for mass-spectrometry-based detection of non-canonical peptides
|
|
WO2026159255A1
(en)
|
2025-01-24 |
2026-07-30 |
BioNTech SE |
Technologies for mutation detection using tumor modeling and feedback
|